Xiao-Yue Ge

469 citations
19 papers · 348 indexed · h-index 11
Topics
Pulmonary Hypertension Research and Treatments (7 papers)MicroRNA in disease regulation (4 papers)Circular RNAs in diseases (4 papers)
Partner nations
China

In The Last Decade

Xiao-Yue Ge

19 papers receiving 343 citations

Peers

Xiao-Yue Ge
Comparison fields: 5 of 70
  • Molecular Biology 160
  • Pulmonary and Respiratory Medicine 134
  • Cancer Research 78
  • Geophysics 66
  • Cardiology and Cardiovascular Medicine 37
Replace Wenxiang Shi with:
Wenxiang Shi China
Carlos Ernesto Fernandez‐Garcia Spain
Péter Germán United States
Masaru Takabatake Japan
Xiaotian Zhang China
Yasuhiro Tsukahara Japan
A Eckert United States
Yajuan Ran China
Kevin P. Hieber United States
Rui Yan China
Xiao-Yue Ge relative to Wenxiang Shi China Wenxiang Shi's profile →
Citations per field
00.5×6.7×
Wenxiang Shi · 1×
Citations per year

Countries citing papers authored by Xiao-Yue Ge

Since Specialization
Citations

This map shows the geographic impact of Xiao-Yue Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Yue Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Yue Ge more than expected).

Fields of papers citing papers by Xiao-Yue Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Yue Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Yue Ge. The network helps show where Xiao-Yue Ge may publish in the future.

Co-authorship network of co-authors of Xiao-Yue Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Yue Ge. A scholar is included among the top collaborators of Xiao-Yue Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Yue Ge. Xiao-Yue Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 10
2 5
3 10
4 15
5 6
6 19
7 12
8 32
9 32
10 6
11 17
12 39
13 29
14 6
15 6
16 3
17 26
18 8
19 67

About Xiao-Yue Ge

Xiao-Yue Ge is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 19 papers that have together received 348 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (7 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (78 citations), Geophysics (66 citations) and Pulmonary and Respiratory Medicine (134 citations). Xiao-Yue Ge has collaborated with scholars based in China. Frequent co-authors include Chang-Ping Hu, Tiantian Zhu, Weifang Zhang, Zheng Zhang, Ning Huang, Ting Liu, Hong Liu, Zheng Zhang, Xiaozhou Zou and Xian‐Zhe Dong. Their work appears in journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026